New study explores safer buprenorphine dosing for opioid users
NCT ID NCT06086275
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 33 times
Summary
This study looked at how the body processes buprenorphine, a medication used to treat opioid use disorder, when given by mouth in low doses. Healthy adults with past opioid use received single doses of buprenorphine in different forms, and blood samples were taken to measure drug levels. The goal was to gather information that could help develop safer, more comfortable ways to start buprenorphine treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.